Caption Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8,100
Closed -$1.24M 1570
2025
Q3
$1.24M Sell
8,100
-26,900
-77% -$4.07M 0.01% 1034
2025
Q2
$4.89M Sell
35,000
-115,000
-77% -$16.1M 0.05% 413
2025
Q1
$22.1M Buy
150,000
+138,500
+1,204% +$20M 0.21% 84
2024
Q4
$1.51M Sell
11,500
-113,000
-91% -$15.8M 0.01% 795
2024
Q3
$19.4M Buy
+124,500
New +$20.1M 0.31% 70
2023
Q4
Sell
-32,500
Closed -$4.4M 1332
2023
Q3
$4.4M Buy
32,500
+17,500
+117% +$2.39M 0.07% 353
2023
Q2
$2.15M Sell
15,000
-39,250
-72% -$5.78M 0.04% 479
2023
Q1
$7.53M Buy
54,250
+20,850
+62% +$2.81M 0.15% 162
2022
Q4
$4.53M Sell
33,400
-48,300
-59% -$6.06M 0.07% 326
2022
Q3
$8.96M Buy
+81,700
New +$10.4M 0.12% 199
2022
Q1
Sell
-120,400
Closed -$14M 1458
2021
Q4
$14M Sell
120,400
-320,000
-73% -$37.7M 0.16% 165
2021
Q3
$52.9M Buy
440,400
+279,600
+174% +$32.5M 0.6% 12
2021
Q2
$19.3M Buy
+160,800
New +$17.6M 0.25% 89
2020
Q3
Sell
-158,150
Closed -$16.7M 1030
2020
Q2
$16.7M Buy
+158,150
New +$16.3M 0.56% 22

Other funds holding AZN

Caption Management's AZN Position: Q1 2026 in Review

Caption Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 88,950 shares — an estimated $17.2M sold.

Caption Management first reported a position in AZN in Q2 2020 and held it in 17 quarters. The position peaked at $16.4M in Q4 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Caption Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 88,950 AstraZeneca shares in Q1 2026, an estimated $17.2M.
  • Caption Management first reported a position in AstraZeneca in Q2 2020 and held it in 17 quarters.
  • Caption Management's AstraZeneca position peaked at $16.4M in Q4 2025.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.